2.4.0.6 Html 21 111 1 false 7 0 false 4 false false R1.htm 001 - Document - DOCUMENT AND ENTITY INFORMATION Sheet http://www.capstonethx.com/role/DocumentAndEntityInformation DOCUMENT AND ENTITY INFORMATION true false R2.htm 002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS Sheet http://www.capstonethx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS CONDENSED CONSOLIDATED BALANCE SHEETS false false R3.htm 003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS [Parenthetical] Sheet http://www.capstonethx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical CONDENSED CONSOLIDATED BALANCE SHEETS [Parenthetical] false false R4.htm 004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS Sheet http://www.capstonethx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS false false R5.htm 005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS [Parenthetical] Sheet http://www.capstonethx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSParenthetical CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS [Parenthetical] false false R6.htm 006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://www.capstonethx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS false false R7.htm 007 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://www.capstonethx.com/role/SummaryOfSignificantAccountingPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES false false R8.htm 008 - Disclosure - CASH AND CASH EQUIVALENTS Sheet http://www.capstonethx.com/role/CashAndCashEquivalents CASH AND CASH EQUIVALENTS false false R9.htm 009 - Disclosure - JOINT VENTURE FOR DEVELOPMENT OF APO E MIMETIC PEPTIDE MOLECULE AEM-28 AND ANALOGS Sheet http://www.capstonethx.com/role/JointVentureForDevelopmentOfApoEMimeticPeptideMoleculeAem28AndAnalogs JOINT VENTURE FOR DEVELOPMENT OF APO E MIMETIC PEPTIDE MOLECULE AEM-28 AND ANALOGS false false R10.htm 010 - Disclosure - CONTINGENCY LEGAL PROCEEDINGS Sheet http://www.capstonethx.com/role/ContingencyLegalProceedings CONTINGENCY LEGAL PROCEEDINGS false false R11.htm 011 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://www.capstonethx.com/role/SummaryOfSignificantAccountingPoliciesPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) false false R12.htm 012 - Disclosure - JOINT VENTURE FOR DEVELOPMENT OF APO E MIMETIC PEPTIDE MOLECULE AEM-28 AND ANALOGS (Tables) Sheet http://www.capstonethx.com/role/JointVentureForDevelopmentOfApoEMimeticPeptideMoleculeAem28AndAnalogsTables JOINT VENTURE FOR DEVELOPMENT OF APO E MIMETIC PEPTIDE MOLECULE AEM-28 AND ANALOGS (Tables) false false R13.htm 013 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Textual) Sheet http://www.capstonethx.com/role/SummaryOfSignificantAccountingPoliciesDetailsTextual SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Textual) false false R14.htm 014 - Disclosure - CASH AND CASH EQUIVALENTS (Details Textual) Sheet http://www.capstonethx.com/role/CashAndCashEquivalentsDetailsTextual CASH AND CASH EQUIVALENTS (Details Textual) false false R15.htm 015 - Disclosure - JOINT VENTURE FOR DEVELOPMENT OF APO E MIMETIC PEPTIDE MOLECULE AEM-28 AND ANALOGS (Details) Sheet http://www.capstonethx.com/role/JointVentureForDevelopmentOfApoEMimeticPeptideMoleculeAem28AndAnalogsDetails JOINT VENTURE FOR DEVELOPMENT OF APO E MIMETIC PEPTIDE MOLECULE AEM-28 AND ANALOGS (Details) false false R16.htm 016 - Disclosure - JOINT VENTURE FOR DEVELOPMENT OF APO E MIMETIC PEPTIDE MOLECULE AEM-28 AND ANALOGS (Details Textual) Sheet http://www.capstonethx.com/role/JointVentureForDevelopmentOfApoEMimeticPeptideMoleculeAem28AndAnalogsDetailsTextual JOINT VENTURE FOR DEVELOPMENT OF APO E MIMETIC PEPTIDE MOLECULE AEM-28 AND ANALOGS (Details Textual) false false All Reports Book All Reports Element caps_InvestmentsInAndAdvanceToAffiliatesAdditionalPerformanceMeasuredIncentiveFee had a mix of decimals attribute values: -5 0. 'Monetary' elements on report '013 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Textual)' had a mix of different decimal attribute values. 'Monetary' elements on report '016 - Disclosure - JOINT VENTURE FOR DEVELOPMENT OF APO E MIMETIC PEPTIDE MOLECULE AEM-28 AND ANALOGS (Details Textual)' had a mix of different decimal attribute values. Process Flow-Through: 002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS Process Flow-Through: Removing column 'Mar. 31, 2012' Process Flow-Through: Removing column 'Dec. 31, 2011' Process Flow-Through: Removing column 'Aug. 04, 2004' Process Flow-Through: 003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS [Parenthetical] Process Flow-Through: 004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS Process Flow-Through: 005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS [Parenthetical] Process Flow-Through: 006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Process Flow-Through: Removing column '12 Months Ended Dec. 31, 2012' caps-20130331.xml caps-20130331.xsd caps-20130331_cal.xml caps-20130331_def.xml caps-20130331_lab.xml caps-20130331_pre.xml true true